Magnetic Microspheres as Targeted Drug Delivery Systems: An Overview of Design and Therapeutic Applications

Consequently, magnetic targeting allows the administration of lower systemic drug doses while achieving significantly higher localized drug levels at the disease site. ^[10]

MAGNETIC PROPERTIES OF MICROSPHERES

Magnetic microspheres used for bio separation typically comprise one or more magnetic cores encapsulated within a coating matrix made of polymers, silica, or hydroxyapatite, which is further functionalized with terminal reactive groups. The magnetic core is most commonly composed of magnetite (Fe?O?) or maghemite (γ-Fe?O?), exhibiting either superparamagnetic or ferromagnetic behaviour. In addition to iron oxides, magnetic cores may also be fabricated from magnetic ferrites such as cobalt ferrite or manganese ferrite. Superparamagnetism arises when the magnetic dipole moment of a single-domain particle undergoes rapid fluctuations due to thermal excitation, resulting in the absence of a net magnetic moment over macroscopic time scales. Consequently, these particles exhibit no residual magnetism in the absence of an external magnetic field but acquire a significant and reversible magnetic moment when subjected to an applied magnetic field. ^[9]

Figure 1: Super paramagnetic particles under the influence of external magnetic field.

Figure 2: Super paramagnetic particles in absence of an external magnetic field, monodisperse particle distribution.

The ferromagnetic particles are those particles having a permanent mean magnetic moment (Fig 1 and Fig 2). Here, the larger effective magnetic anisotropy suppresses the thermally activated motion of the core moments.

Figure 3: Ferromagnetic particles under the influence of an external magnetic field.

Figure 4: Ferromagnetic particles in absence of an external magnetic field

Superparamagnetic and ferromagnetic particles are widely recommended for automated DNA and RNA separation and purification processes. For instance, SiMAG/K-DNA and SiMAG/MP-DNA beads have been specifically developed for the automated isolation of various nucleic acids, including genomic DNA, plasmid DNA, total RNA, and PCR products. Under high-salt conditions, such as 5 M guanidinium thiocyanate, DNA and RNA efficiently bind to the porous silica surface of these beads. Both superparamagnetic SiMAG/K-DNA beads and ferromagnetic SiMAG/MP-DNA beads exhibit excellent magnetic responsiveness, making them highly suitable for automated nucleic acid separation and purification. As different robotic platforms employ distinct processing and magnetic separation mechanisms, the use of either superparamagnetic or ferromagnetic SiMAG-DNA beads can be selected to achieve optimal performance. ^[10]

METHODS OF PREPARATION OF MAGNETIC MICROSPHERES

1. Solvent evaporation

Polymer-encapsulated magnetic microspheres are commonly prepared using the continuous solvent evaporation technique. In this method, the polymer, drug, and magnetite are dissolved or dispersed in a volatile organic solvent to form an auxiliary solution under continuous stirring. The resulting mixture is subsequently homogenized and maintained under stirring at a controlled temperature ranging from 22 to 30 °C to facilitate microsphere formation. The formed magnetic microspheres are then collected by centrifugation, followed by freeze-drying, and finally stored at 4 °C for further use. ^[9,11]

2. Multiple emulsion method                                                                                                   

This technique involves the formation of multiple emulsions of the water-in-oil-in-water (w/o/w) type and is particularly suitable for encapsulating water-soluble drugs, peptides, proteins, and vaccines. The method is applicable to both natural and synthetic polymers. Initially, an aqueous protein solution containing the active constituents is dispersed into a lipophilic organic continuous phase. This organic phase typically consists of a polymer solution, which ultimately encapsulates the protein present in the dispersed aqueous phase. The resulting primary emulsion is subjected to homogenization or sonication and subsequently added to an aqueous polyvinyl alcohol solution to form a multiple emulsion. The emulsion is then processed for solvent removal, either through solvent evaporation or solvent extraction. Using this approach, a wide range of hydrophilic compounds, including indomethacin, luteinizing hormone-releasing hormone (LHRH) agonists, vaccines, proteins, peptides, and conventional drug molecules, have been successfully incorporated into microspheres. ^[12,13]

3. Phase separation emulsion polymerization

In this method, an aqueous solution containing the polymer, drug, and magnetite is added to a vegetable oil phase and emulsified using a magnetic stirrer. The resulting emulsion is stabilized by heating at temperatures ranging from 100 to 150 °C. Subsequently, a cross-linking agent is introduced dropwise into the emulsion under continuous stirring to facilitate microsphere formation. The formed magnetic microspheres are then separated from the oil phase through successive washing steps. Finally, the product is freeze-dried and stored at 4 °C for
further use.^[9]

4. Emulsion solvent extraction method

The preparation process initially involved dispersing an aqueous phase containing magnetite nanoparticles and a water-soluble homopolymer into fine droplets within an organic medium, using an amphiphilic block copolymer as the dispersing agent. This step was followed by water distillation from the aqueous droplets at elevated temperatures, leading to the formation of polymer–magnetite composite particles. The structural integrity of the particles was subsequently stabilized by the addition of a cross-linking reagent, which cross-linked the water-soluble blocks of both the copolymer and the homopolymer. As the hydrophobic block of the copolymer was composed of a protected polyester, removal of the protective groups from the coronal chains resulted in the formation of poly(acrylic acid) or other functional polymers. This modification imparted water dispersibility to the microspheres and enabled effective biomolecule immobilization. ^[9]

5. Hot melt microencapsulation

In this method, the polymer is first melted and subsequently blended with solid drug particles that have been sieved to a size below 50 μm. The resulting mixture is then suspended in a non-miscible solvent, such as silicone oil, and continuously stirred while being heated to approximately 5 °C above the polymer’s melting point. After stabilization of the emulsion, the system is cooled to allow solidification of the polymer droplets into microspheres. The formed microspheres are recovered and washed by decantation using petroleum ether. This technique was primarily developed to enable microencapsulation of water-labile polymers, such as polyanhydrides. Microspheres with diameters ranging from 1 to 1000 μm can be produced, and particle size distribution can be readily controlled by adjusting the stirring speed. However, a limitation of this method is the exposure of the drug to moderately elevated temperatures during processing. ^[11]

6. Dispersion copolymerization

This method is based on the reaction of complementary monomers at the interface of two immiscible liquid phases, leading to the formation of a polymeric film that effectively encapsulates the dispersed phase. In this technique, two reactive monomers are used, with one monomer dissolved in the continuous phase and the other dispersed within it. Amphiphilic magnetic microspheres with particle sizes ranging from 5 to 100 µm have been successfully prepared via dispersion copolymerization of styrene and polyethylene oxide–vinyl benzyl (PEO-VB) macromonomer in the presence of Fe?O? magnetic fluid. The average microsphere size was observed to increase with higher styrene concentrations and with decreasing molecular weight of the PEO-VB macromonomer. ^[14]

7. Microwave-assisted preparation of magnetic albumin microspheres

The microwave-assisted technique has been employed for the preparation of magnetic bovine serum albumin microspheres. Compared with conventional methods, this approach is faster and results in the formation of smaller particle sizes. Optimal conditions for the synthesis of albumin-loaded magnetic microspheres were achieved by microwave irradiation for 4 minutes at 160 °C, producing microspheres with an average diameter of approximately 30 µm. Owing to its efficiency and ability to generate uniformly sized particles, the microwave-assisted process shows strong potential as a preferred method for the fabrication of magnetized protein microspheres. ^[15]

EVALUATION AND CHARACTERIZATION OF MAGNETIC MICROSPHERES

1. Particle size and shape

The most commonly employed techniques for the visualization of microspheres include conventional light microscopy (LM) and scanning electron microscopy (SEM). Both methods are effective for assessing the shape and surface morphology of microspheres. Light microscopy is particularly useful for monitoring coating parameters in double-walled microspheres, as it enables visualization of particle structure before and after coating and allows microscopic measurement of structural changes. In contrast, SEM offers significantly higher resolution than LM, permitting detailed examination of microsphere surface characteristics. Furthermore, following particle cross-sectioning, SEM can be utilized to investigate the internal architecture of double-walled microsphere systems. Confocal fluorescence microscopy is employed for structural characterization of multi-walled microspheres. In addition to microscopic techniques, particle size characterization can be performed using instrumental methods such as laser light scattering and multi-size Coulter counter analysis. ^[16]

2. Electron spectroscopy for chemical analysis                                                                                                  

The surface chemistry of microspheres can be characterized using electron spectroscopy for chemical analysis (ESCA). This technique enables precise determination of the atomic composition of the microsphere surface. Additionally, the spectra obtained through ESCA can be utilized to assess surface degradation phenomena in biodegradable microspheres. ^[14]

3.  Swelling Index

The swelling index was determined by evaluating the extent of microsphere swelling in the specified buffer medium. To achieve equilibrium swelling, a precisely weighed quantity of microspheres was immersed in the buffer for a predetermined period. After swelling, excess surface-adhered liquid was carefully removed by blotting, and the swollen microspheres were weighed using a microbalance. The hydrogel microspheres were then dried in an oven at 60 °C for 5 hours, or until a constant dry weight was obtained. ^[14]                                                                                                                                

The swelling index of the microspheres was calculated using the following equation:

Swelling Index (%)=Mass of swollen microspheres-Mass of dried microspheresMass of dried microspheres×100

4. Flow Properties

1. Density

i. Bulk density

Bulk density was determined by gently pouring a known weight of microspheres into a graduated measuring cylinder without tapping and recording the occupied volume. The bulk density was calculated by dividing the mass of the sample by its bulk volume.

ii. Tapped density

Tapped density was measured by placing a known weight of microspheres into a measuring cylinder, followed by mechanical or manual tapping until a constant volume was achieved. The tapped density was then calculated as the ratio of the sample mass to the tapped volume.

2.  Hausner ratio

The Hausner ratio, defined as the ratio of tapped density to bulk density, was used to assess the flow characteristics of the microspheres. A Hausner ratio value of less than 1.2 indicates good flowability, whereas higher values suggest poor flow properties.

3. Angle of repose

The angle of repose is defined as the maximum angle formed between the surface of
a pile of microspheres and the horizontal plane. It is commonly determined using methods such as the fixed-height cone or fixed-base cone techniques. A high angle of repose indicates poor flow behaviour, while a lower angle corresponds to free-flowing microspheres. ^[14]

5. Surface charge analysis

The surface charge of microspheres can be determined using micro-electrophoresis, a technique employed to measure the electrophoretic mobility of particles, from which the isoelectric point can be estimated. The mean particle velocity is calculated at different pH values, typically ranging from 3 to 10, by measuring the time required for the microspheres to migrate over a fixed distance of 1 mm. Based on these measurements, the electrophoretic mobility of the particles is determined. The obtained electrophoretic mobility values are directly related to the surface charge characteristics and ion adsorption behaviour of the microspheres. ^[17]

6. Drug release profiles

1. In vitro methods

Reliable experimental methods are essential for evaluating the drug release characteristics and membrane permeability of pharmaceutical formulations. To address this need, various in vitro and in vivo techniques have been reported in the literature. In vitro drug release studies are widely employed as quality control tools during pharmaceutical product development and manufacturing. Standard USP or BP dissolution apparatus are commonly used to investigate in vitro release profiles, utilizing either paddle or basket configurations. The dissolution medium volume typically ranges from 100 to 500 mL, while the rotation speed is maintained between 50 and 100 rpm to ensure reproducible release conditions. ^[18]

2. In vivo methods                                                                                                                      

The most widely used in-vivo methods are the use of animal models and buccal absorption tests:

Animal models

Animal models primarily serve to screen series of compounds, investigate the mechanisms and efficacy of permeation enhancers, or evaluate formulation sets. Various animal models have been documented in the literature, though in vivo studies remain limited. These include dogs, rats, rabbits, cats, hamsters, pigs, and sheep. Typically, the procedure entails anesthetizing the animal and administering the dosage form. For rats, the oesophagus is ligated to restrict absorption to the oral mucosa alone. Blood samples are then collected at predetermined intervals and analysed.

Buccal Absorption Test

The buccal absorption test, developed by Beckett and Triggs in 1967, offers a straightforward and reliable approach to quantify drug absorption in the human oral cavity from single or multi-component drug mixtures. It has proven effective in assessing the influence of key factors such as drug structure, contact time, initial concentration, and solution pH on absorption while the drug remains in the mouth.

3. In vitro-In vivo correlations                                                                                 

Correlations between in vitro dissolution rates and the rate and extent of availability as determined by blood concentration and or urinary excretion of drug or metabolites are referred to as “in vitro-in vivo correlations”. Such correlations allow one to develop product specifications with bioavailability.

Percent of Drug Dissolved In Vitro vs. Peak Plasma Concentration

This method correlates the in vitro percentage of drug released from various dosage forms with their peak plasma concentrations achieved in vivo. Poorly formulated products typically exhibit low dissolution rates alongside reduced peak plasma levels.

Percent of Drug Dissolved vs. Percent of Drug Absorbed

For hydrophobic drugs, where dissolution is the rate-limiting step in absorption, a linear correlation often exists between the percent of drug dissolved in vitro and the percent absorbed in vivo. In contrast, for hydrophilic drugs where absorption itself limits bioavailability variations in dissolution rate typically do not affect the rate or extent of drug absorption from the dosage form.

Dissolution Time vs. Absorption Time

In analyses of in vitro-in vivo drug correlations, rapid drug absorption can be distinguished from slower absorption by observing the absorption time for the dosage form. The faster the drug absorption, the less time required to absorb a given amount of drug. The time needed to absorb a specific amount of drug from the dosage form correlates with the time required for the same amount to dissolve in vitro.

Percent of Drug Dissolved vs. Serum Drug Concentration                                            

For drugs whose absorption from the gastrointestinal tract (GIT) is limited by dissolution rate, a linear correlation can be established between the percent of drug dissolved at specific times and the serum drug concentrations at corresponding times.

Percent of Drug Dissolved vs. Percent of Dose Excreted in Urine

Since the percent of drug dissolved correlates linearly with the percent absorbed, a corresponding correlation exists between the amount of drug in the body and the amount excreted in urine. Thus, a linear relationship can be established between the percent of drug dissolved and the percent of the dose excreted in urine. ^[18]

7. Determination of Drug Content and Entrapment Efficiency of Microspheres

An accurately weighed quantity of microspheres was finely crushed using a glass mortar and pestle, and the resulting powder was dispersed in a predetermined volume of an appropriate solvent. The dispersion was allowed to stand for 12 hours to ensure complete extraction of the drug. The solution was then filtered, and the filtrate was analyzed for drug content using a UV–visible spectrophotometer. The drug content, which corresponds to the entrapment efficiency, was calculated as the ratio of the actual amount of drug present in the microspheres to the theoretical drug content. ^[19]

FACTORS INFLUENCING THE PROPERTIES OF MICROSPHERES

1. Polymers

Polymers commonly employed for microsphere preparation should be stable, biocompatible, and biodegradable, with tunable mechanical properties and a wide range of erosion rates. They should exhibit favorable degradation characteristics and allow for sustained drug delivery. The degradation byproducts must be non-toxic and readily eliminated via normal metabolic pathways. Additionally, the polymer must be capable of delivering the drug at the desired concentration, distribution, and duration to achieve the intended therapeutic effect. ^[9]

2. Choice of Solvent/Co-solvent System

The solvent system should efficiently dissolve the selected polymer while remaining poorly soluble in the continuous phase. Ideal solvents possess high volatility, low boiling points, and minimal toxicity. ^[9]

3. Other Components

a) Porosity Generators: These agents enhance polymer degradation and improve drug release. For example, the incorporation of Sephadex into insulin-loaded polylactide microspheres significantly increases microsphere porosity. ^[20]

b) Surfactants: Surfactants reduce the surface tension of the continuous phase, preventing coalescence and agglomeration of droplets and stabilizing the emulsion. Commonly used surfactants include:

• Non-ionic: Methylcellulose, Tween, Span

• Anionic: Sodium dodecyl sulfate (SDS)
• Cationic: Cetyl trimethyl ammonium bromide (CTAB)

c) Antifoaming Agents: Foam formation can interfere with microsphere preparation. To prevent this, antifoaming agents such as silicone-based compounds (e.g., dimethicone) and non-silicone agents (e.g., Spans) are commonly used. ^[20]

Applications of Magnetic Microspheres

1. Biomedical and Bioengineering Applications: Magnetic microsphere carriers have attracted significant attention due to their versatile applications in biomedicine and bioengineering. They are widely used in enzyme immobilization, cell isolation, protein purification, and targeted drug delivery. ^[21]
2. Targeted Drug Delivery: Magnetic microspheres are particularly attractive for therapeutic agent delivery because they can be guided to specific sites in the body using an external magnetic field gradient. This magnetic localization concentrates the therapeutic agent at the target site, thereby minimizing or eliminating systemic side effects. ^[22]
3. Cancer Therapy: Magnetic microspheres have been employed to target chemotherapeutic agents such as mitoxantrone, paclitaxel, and doxorubicin to tumour tissues. Microsphere carriers labelled with radionuclides, including Rhenium-188 and Yttrium-90, have also been investigated in preclinical studies for the treatment of liver and brain tumours. ^[23]
4. Hyperthermia Treatment: Magnetic microspheres loaded with cisplatin or paclitaxel have been utilized for localized hyperthermia as a cancer treatment strategy. ^[24]
5. Stem Cell and Bone Marrow Applications: Magnetic microspheres can be used for stem cell extraction and bone marrow purging, facilitating targeted isolation of desired cell populations. ^[25]
6. Cell Labelling: Magnetic polystyrene microspheres have been employed for specific cell labelling in various research and diagnostic applications. ^[26]
7. Biomolecule Isolation: Advances in solid-phase methods have improved the isolation of DNA, proteins, cells, and organelles. Silica-coated magnetic particles, for example, enable rapid and efficient DNA purification and make automation of the process feasible. ^[27]
8. Biomolecule Detection and Quantification: Commercially available instruments now integrate magnetic separation with detection methods, including fluorescence or chemiluminescence, for the quantification and interaction studies of biomolecules. Some assays employ ferromagnetic particles directly as labels (magneto assays). ^[28]
9. Immobilization of Proteins, Enzymes, and Drugs: Magnetic microspheres serve as carriers for covalent binding of proteins, enzymes, or drugs, typically in the presence of carbodiimide. Immobilized biomolecules can be used in bioassays or as affinity ligands to capture, modify, or detect target molecules or cells, with broad applications in medicine and biotechnology. ^[29] 
10. Bacterial Detection: Streptavidin-coated magnetic beads have been applied for the detection of bacteria. ^[30]
11. Cancer Metastasis Detection: Superparamagnetic iron oxide microspheres have been employed to detect metastases in non-enlarged lymph nodes. ^[31]
12. Immune-Magnetic Cell Enrichment: Magnetic Dyn beads are utilized in immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. ^[32]
13. Contraceptive Applications: Magnetic microsphere carriers responsive to steroid fluctuations during the menstrual cycle have been designed for controlled contraceptive delivery. ^[33]

CONCLUSION

Magnetic microspheres represent an advanced and versatile drug delivery platform capable of achieving site-specific localization of therapeutic agents through external magnetic guidance. Their ability to enhance drug bioavailability, reduce systemic toxicity, and provide controlled and sustained drug release makes them particularly valuable in the treatment of cancer and other localized diseases. Various preparation techniques and polymers allow flexibility in tailoring microsphere properties such as size, morphology, magnetic responsiveness, and release kinetics. Despite certain limitations related to cost, technical complexity, and magnetic field requirements, ongoing research continues to address these challenges. With continuous advancements in material science and formulation technologies, magnetic microspheres are expected to play an increasingly important role in targeted therapy, diagnostics, and biomedical engineering.

REFERENCES

1. Jain NK, editor. Controlled and novel drug delivery. New Delhi: CBS publishers & distributors; 1997.
2. Poovi G, Padmapriya S, Lakshmi S. Review on magnetic microsphere. Global Journal of Pharmacology. 2015;9(4):296-310.
3. Varma VK, Amareshwar P, Hemamalini K, Sreenivas K, Babu AK, Kranthi K. Preparation and in vitro evaluation of Diclofenac Sodium loaded Ethyl cellulose composite magnetic microspheres. International Journal of Pharmaceuticals Analysis. 2009 Jan 1;1(2):40.
4. Asmatulu R, Zalich MA, Claus RO, Riffle JS. Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. Journal of Magnetism and Magnetic Materials. 2005 Apr 1; 292:108-19.
5. Kavita K, Ashvini VR, Ganesh NS. Albumin microspheres. Unique system as drug delivery carriers for non-steroidal anti-inflammatory drugs. Int J Pharm Sci Rev Res. 2010;5(2):10.
6. Li SP, Kowarski CR, Feld KM, Grim WM. Recent advances in microencapsulation technology and equipment. Drug Development and Industrial Pharmacy. 1988 Jan 1;14(2-3):353-76.
7. Shanthi NC, Gupta R, Mahato KA. Traditional and emerging applications of microspheres: A review. International Journal of Pharm Tech Research. 2010;2(1):675-81.
8. Farah FH. Magnetic microspheres: a novel drug delivery system. J. Anal. Pharm. Res. 2016 Nov 3;3(10.20959).
9. Singh C, Purohit S, Singh M, Pandey BL. Design and evaluation of microspheres: A Review. Journal of drug delivery research. 2013;2(2):18-27.
10. Mathew Sam T, Devi Gayathri S, Prasanth VV, Vinod B. Suitability of factorial design in determining the processing factors affecting entrapment efficiency of albumin microspheres. Journal of Pharmacy Research. 2010;3(5):1172-7.
11. Parmar H, Bakliwal S, Gujarathi N, Rane B, Pawar S. Different methods of formulation and evaluation of mucoadhesive microsphere.
12. Alagusundaram M, Chetty MS, Umashankari K, Badarinath AV, Lavanya C, Ramkanth S. Microspheres as a novel drug delivery system-a review. Int J Chem Tech Res. 2009 Jul;1(3):526-34.
13. Sam MT, Gayathri DS, Prasanth V, Vinod B. NSAIDs as microspheres. Internet J Pharmacol. 2008;6(1):1-8.
14. Vyas SP, Khar RK. Targeted & controlled drug delivery: novel carrier systems. CBS publishers & distributors; 2004.
15. Chen CY, Long Q, Li XH, Xu J. Microwave-assisted preparation of magnetic albumin microspheres. Journal of Bioactive and Compatible Polymers. 2008 Sep;23(5):490-500.
16. Prasanth VV, Moy AC, Mathew ST, Mathapan R. Microspheres-an overview. International journal of research in pharmaceutical and biomedical sciences. 2011 Apr;2(2):332-8.
17. Patel NR, Patel DA, Bharadia PD, Pandya V, Modi D. Microsphere as a novel drug delivery. International Journal of Pharmacy & Life Sciences. 2011 Aug 1;2(8).
18. Soni ML, Kumar M, Namdeo KP. Sodium alginate microspheres for extending drug release: formulation and in vitro evaluation. International journal of drug delivery. 2010 Jan 1;2(1).
19. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Microsphere: A review. Int. J. Res. Pharm. Chem. 2011;1(4):1184-98.
20. Hu YQ, Guo JX, Wang LJ, Tan R, Zhen LY. Preparation and evaluation of insulin-loaded polylactide microspheres using factorial design. Drug development and industrial pharmacy. 2000 Jan 1;26(12):1309-13.
21. Šafa?ík I, Šafa?íková M. Magnetic nanoparticles and biosciences. Monatshefte für Chemie/Chemical Monthly. 2002 Jun;133(6):737-59.
22. Lübbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. Journal of Surgical Research. 2001 Feb 1;95(2):200-6.
23. Schütt W, Grüttner C, Teller J, Westphal F, Häfeli U, Paulke B, Goetz P, Finck W. Biocompatible magnetic polymer carriers for in vivo radionuclide delivery. Artificial Organs. 1999 Jan;23(1):98-103.
24. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening S, Lanksch W. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. Journal of magnetism and magnetic materials. 2001 Jan 1;225(1-2):118-26.
25. Häfeli U. Radioactive microspheres for medical applications. Physics and chemistry basis of biotechnology. 2001:213-48.
26. Šafa???k I, Šafa???ková M. Use of magnetic techniques for the isolation of cells. Journal of Chromatography B: Biomedical Sciences and Applications. 1999 Feb 5;722(1-2):33-53.
27. Saiyed ZM, Telang SD, Ramchand CN. Application of magnetic techniques in the field of drug discovery and biomedicine. BioMagnetic research and Technology. 2003 Sep 18;1(1):2.
28. Koneracka M, Kop?anský P, Timko M, Ramchand CN, de Sequeira A, Trevan M. Direct binding procedure of proteins and enzymes to fine magnetic particles. Journal of Molecular Catalysis B: Enzymatic. 2002 Sep 13;18(1-3):13-8.
29. TU SI, UKNALIS J, IRWIN P, YU LS. The use of streptavidin coated magnetic beads for detecting pathogenic bacteria by light addressable potentiometric sensor (LAPS). Journal of Rapid Methods & Automation in Microbiology. 2000 Aug;8(2):95-109.
30. Bahadur D, Giri J. Biomaterials and magnetism. Sadhana. 2003 Jun;28(3):639-56.
31. Naume B, Borgen E, Beiske K, HERSTAD TK, Ravnås G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S, Kvalheim G. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. Journal of hematotherapy. 1997 Apr;6(2):103-14.
32. Chan LW, Heng PW. Effects of poly (vinylpyrrolidone) and ethylcellulose on alginate microspheres prepared by emulsification. Journal of microencapsulation. 1998 Jan 1;15(4):409-20.
33. Saiyed ZM, Telang SD, Ramchand CN. Application of magnetic techniques in the field of drug discovery and biomedicine. BioMagnetic research and Technology. 2003 Sep 18;1(1):2.